Looking Back Over the Last 30 Years, What Advance Has Had the Greatest Impact on the Industry — And Why? Press / Joel E Looking Back Over the Last 30 Years, What Advance Has Had the Greatest Impact on the Industry — And Why? Read More »
The Vanishing Physical Exam in Oncology Press / Joel E The Vanishing Physical Exam in Oncology Read More »
Women in STEM: Early Phase Drug Development Press / Joel E Women in STEM: Early Phase Drug Development Read More »
Assigned Slot Allocation Offers A Fair Solution For Oncology Phase 1 Trial Sponsors, Patients And Providers (Part 2) Press / Joel E Assigned Slot Allocation Offers A Fair Solution For Oncology Phase 1 Trial Sponsors, Patients And Providers (Part 2) Read More »
Slot Allocation Is A Problem For Patients And PIs In Phase 1 Oncology Trials (Part 1) Press / Joel E Slot Allocation Is A Problem For Patients And PIs In Phase 1 Oncology Trials (Part 1) Read More »
IndustrySense Panel Discussion: Early-Phase Oncology Trials: Shaping the Future of Cancer Research Press / Joel E IndustrySense Panel Discussion: Early-Phase Oncology Trials: Shaping the Future of Cancer Research Read More »
Fine-tuning ADCs to Improve Outcomes for Patients with Cancer Press / Joel E Fine-tuning ADCs to Improve Outcomes for Patients with Cancer Read More »
Ethical Concerns if Researchers Fail to Meet Recruitment Targets Press / Lauren Panco Ethical Concerns if Researchers Fail to Meet Recruitment Targets Read More »
Pediatric Oncology Trials in Spain: Meeting Urgent Needs with Innovation and Speed Press / Lauren Panco Pediatric Oncology Trials in Spain: Meeting Urgent Needs with Innovation and Speed Read More »
Beyond Blood Cancers: CAR-T’s Expanding Frontier Press / Lauren Panco Beyond Blood Cancers: CAR-T’s Expanding Frontier Read More »